PubRank

Masaharu Kasai

Author PubWeight™ 33.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2008 1.86
2 Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2008 1.68
3 A case of leukemia of the appendix presenting as acute appendicitis. Acta Haematol 2003 1.30
4 Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). Int J Hematol 2003 0.99
5 Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003 0.99
6 Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood 2006 0.98
7 Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes. Blood 2009 0.98
8 Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003 0.97
9 Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Br J Haematol 2005 0.95
10 Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor. Biol Blood Marrow Transplant 2005 0.94
11 Diffuse large B-cell lymphoma with massive portal vein tumor thrombosis in a patient with alcoholic cirrhosis: a case report and literature review. Intern Med 2009 0.92
12 Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. Biol Blood Marrow Transplant 2010 0.90
13 Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia. Int J Hematol 2010 0.86
14 Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance status. Oncology 2008 0.86
15 A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant 2008 0.85
16 Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Curr Stem Cell Res Ther 2009 0.85
17 Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study. Int J Hematol 2004 0.85
18 Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 2005 0.84
19 Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan. Biol Blood Marrow Transplant 2013 0.84
20 Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation. Leuk Lymphoma 2004 0.83
21 Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208. Cancer Sci 2007 0.82
22 Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years. Int J Hematol 2010 0.81
23 Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Jpn J Clin Oncol 2012 0.81
24 Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan. Int J Hematol 2010 0.79
25 Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients. Am J Hematol 2005 0.79
26 [A case of ischemic colitis induced by preparation in colonoscopic examination]. Nihon Shokakibyo Gakkai Zasshi 2002 0.79
27 [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer]. Gan To Kagaku Ryoho 2006 0.78
28 Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. Br J Haematol 2004 0.78
29 Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients. Eur J Haematol 2006 0.77
30 [Primary adrenal lymphoma: a case report and literature review in Japan]. Rinsho Ketsueki 2002 0.77
31 Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas. Leuk Lymphoma 2010 0.77
32 Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leuk Lymphoma 2012 0.77
33 Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation. Neuropathology 2002 0.77
34 Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies. Intern Med 2007 0.76
35 A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002. Int J Hematol 2004 0.76
36 Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 2004 0.76
37 Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities. Am J Hematol 2005 0.75
38 Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004. Cancer Sci 2007 0.75
39 [A case report--gastric stenosis due to primary gastric malignant lymphoma after administration of R-CHOP]. Gan To Kagaku Ryoho 2009 0.75
40 [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation]. Rinsho Ketsueki 2010 0.75
41 Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. Cancer Sci 2009 0.75
42 A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma. Jpn J Clin Oncol 2003 0.75
43 [Successful treatment of 5-FU intraarterial infusion on the third postoperative day for a patient with multiple liver metastases from colon cancer and high risk of liver failure]. Gan To Kagaku Ryoho 2004 0.75
44 Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia. Acta Med Okayama 2009 0.75
45 [A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction]. Gan To Kagaku Ryoho 2006 0.75
46 [Present status in hematopoietic stem cell transplantation (discussion)]. Nihon Naika Gakkai Zasshi 2005 0.75
47 [Current status of treatment for patients with idiopathic thrombocytopenic purpura in the Hokkaido area (evaluation of Helicobacter pylori eradication)]. Rinsho Ketsueki 2004 0.75
48 Induction of CD94/NKG2A expression on T cells in mixed lymphocyte culture by CD14+ cells from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Br J Haematol 2002 0.75
49 [A case of advanced gastric cancer with liver metastases successively treated with S-1/CDDP combination therapy followed by curative resection]. Gan To Kagaku Ryoho 2012 0.75
50 Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer. Gan To Kagaku Ryoho 2007 0.75
51 Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group. Eur J Haematol 2007 0.75
52 [Survey on the threshold for platelet transfusions]. Rinsho Ketsueki 2004 0.75
53 A case of advanced breast cancer associated with development of liver atrophy with progressive liver failure during treatment. Gan To Kagaku Ryoho 2008 0.75